Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study (TaISENWITCH)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2012 by Lin, Hsi-Hsun, M.D.
Sponsor:
Information provided by (Responsible Party):
Lin, Hsi-Hsun, M.D.
ClinicalTrials.gov Identifier:
NCT01679964
First received: August 30, 2012
Last updated: September 5, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)